Dentsply SironaXRAY
XRAY
0
Funds holding %
of 7,398 funds
0
Analysts bullish %
of 6 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
61% more call options, than puts
Call options by funds: $19.9M | Put options by funds: $12.3M
0% more funds holding in top 10
Funds holding in top 10: 4 [Q3] → 4 (+0) [Q4]
1% less repeat investments, than reductions
Existing positions increased: 122 | Existing positions reduced: 123
1.82% less ownership
Funds ownership: 102.71% [Q3] → 100.89% (-1.82%) [Q4]
6% less funds holding
Funds holding: 378 [Q3] → 354 (-24) [Q4]
18% less first-time investments, than exits
New positions opened: 75 | Existing positions closed: 91
32% less capital invested
Capital invested by funds: $5.62B [Q3] → $3.81B (-$1.82B) [Q4]
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$18
23%
upside
Avg. target
$19.50
33%
upside
High target
$20
37%
upside
6 analyst ratings
1 positive
17%
5 neutral
83%
0 negative
0%
Mizuho Steven Valiquette 29% 1-year accuracy 2 / 7 met price target | 23%upside $18 | Neutral Maintained | 13 Mar 2025 |
Wells Fargo Vik Chopra 36% 1-year accuracy 4 / 11 met price target | 30%upside $19 | Equal-Weight Maintained | 28 Feb 2025 |
Barrington Research Michael Petusky 35% 1-year accuracy 25 / 72 met price target | 37%upside $20 | Outperform Maintained | 28 Feb 2025 |
Baird Jeffrey Johnson 0 / 0 met price target | 37%upside $20 | Neutral Maintained | 28 Feb 2025 |
Jefferies Glen Santangelo 45% 1-year accuracy 5 / 11 met price target | 37%upside $20 | Hold Downgraded | 23 Jan 2025 |
Financial journalist opinion
Based on 20 articles about XRAY published over the past 30 days
Neutral
Accesswire
6 hours ago
Bronstein, Gewirtz & Grossman, LLC Encourages Dentsply Sirona Inc. (XRAY) Stockholders to Inquire about Securities Investigation
NEW YORK, NY / ACCESS Newswire / April 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.

Neutral
Accesswire
2 days ago
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Investors to Learn More About the Investigation
NEW YORK, NY / ACCESS Newswire / March 30, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.

Neutral
Accesswire
5 days ago
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Dentsply Sirona Inc. (XRAY) And Encourages Investors to Reach Out
NEW YORK, NY / ACCESS Newswire / March 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.

Neutral
Accesswire
1 week ago
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Dentsply Sirona Inc. (XRAY) And Encourages Stockholders to Reach Out
NEW YORK, NY / ACCESS Newswire / March 25, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.

Positive
Benzinga
1 week ago
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Neutral
Accesswire
1 week ago
Bronstein, Gewirtz & Grossman, LLC Is Investigating Dentsply Sirona Inc. (XRAY) And Encourages Stockholders to Connect
NEW YORK, NY / ACCESS Newswire / March 23, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.

Neutral
Accesswire
1 week ago
Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.

Neutral
Accesswire
2 weeks ago
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Stockholders to Learn More About the Investigation
NEW YORK, NY / ACCESS Newswire / March 18, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.

Neutral
GlobeNewsWire
2 weeks ago
Dentsply Sirona Appoints David Ferguson as Global Business Unit Leader
CHARLOTTE, N.C., March 17, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (XRAY) today announced that David Ferguson has been appointed Senior Vice President, Global Business Unit Leader, effective March 14, 2025. In this role he will lead the global business unit teams managing the dental product portfolio, serve as a member of the Executive Management Team and report directly to Chief Executive Officer, Simon Campion.

Neutral
GlobeNewsWire
2 weeks ago
Europe Dental Imaging Device Market Analysis 2025-2031, with Focus on Key Market Leaders including Dentsply Sirona, Carestream Dental, 3Shape and more
Dublin, March 17, 2025 (GLOBE NEWSWIRE) -- The "Dental Imaging Device Market Size, Share & Trends Analysis | Europe | 2025-2031 | MedSuite | Includes: Intraoral X-Ray Imaging Equipment Market, Extraoral X-ray Imaging Market, and 3 more" report has been added to ResearchAndMarkets.com's offering.

Charts implemented using Lightweight Charts™